💉 COVID-19
VACCINE TRIAL SUBJECTS AT RISK OF COVID-19 VACCINES WORSENING CLINICAL DISEASE COVID-19 vaccines designed to elicit neutralising antibodies
may sensitise vaccine recipients to more severe disease than if they were not vaccinated. Vaccines for SARS, MERS and RSV have never been approved, and the data generated in the development and testing of these vaccines
suggest a serious mechanistic concern: that vaccines designed empirically using the traditional approach (consisting of the unmodified or minimally modified coronavirus viral spike to elicit neutralising antibodies), be they composed of protein, viral vector, DNA or RNA and
irrespective of delivery method, may worsen COVID-19 disease via antibody-dependent enhancement (ADE).THIS STUDY CAME OUT IN MARCH 2021 - HOW MANY HAVE SEEN IT? https://pubmed.ncbi.nlm.nih.gov/33113270/@intelops